Paper8551569
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
Trkola A and 9 others. J Virol, 1996. Cited by 991 papers, by iCite.
Cite this record
ConductScience Library. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. Papers, record 8551569. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8551569
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Epitope Mapping | Major topic |
| HIV Antibodies | Major topic |
| HIV Envelope Protein gp120 | Major topic |
| HIV-1 | Major topic |
| Amino Acid Sequence | |
| Antibody-Dependent Cell Cytotoxicity | |
| Cell Line | |
| Complement C3 | |
| Giant Cells | |
| Glycosylation | |
| Humans | |
| Molecular Sequence Data | |
| Mutation | |
| Neutralization Tests | |
| Polysaccharides |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| N01 AI35168 | NIAID NIH HHS | United States | N01AI035168 | PubMed and NIH | NIH RePORTER |
| R01 AI25541 | NIAID NIH HHS | United States | R01AI025541 | PubMed and NIH | NIH RePORTER |
| R01 AI36082 | NIAID NIH HHS | United States | R01AI036082 | PubMed and NIH | NIH RePORTER |
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1700828 | Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. | J Virol | 1990 | https://conductscience.org/library/papers/1700828 | PubMed |
| 2 | 7769703 | Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. | J Virol | 1995 | https://conductscience.org/library/papers/7769703 | PubMed |
| 3 | 1702163 | Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. | J Virol | 1991 | https://conductscience.org/library/papers/1702163 | PubMed |
| 4 | 2014246 | Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/2014246 | PubMed |
| 5 | 1863402 | Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group. | AIDS | 1991 | https://conductscience.org/library/papers/1863402 | PubMed |
| 6 | 1717717 | Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. | J Virol | 1991 | https://conductscience.org/library/papers/1717717 | PubMed |
| 7 | 1717992 | Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1717992 | PubMed |
| 8 | 1718036 | Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. | Science | 1991 | https://conductscience.org/library/papers/1718036 | PubMed |
| 9 | 1370558 | Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. | J Virol | 1992 | https://conductscience.org/library/papers/1370558 | PubMed |
| 10 | 1722676 | Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1. | AIDS | 1991 | https://conductscience.org/library/papers/1722676 | PubMed |
| 11 | 1724568 | A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity. | Res Virol | 1991 | https://conductscience.org/library/papers/1724568 | PubMed |
| 12 | 1599752 | Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains. | AIDS Res Hum Retroviruses | 1992 | https://conductscience.org/library/papers/1599752 | PubMed |
| 13 | 1380099 | Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. | J Virol | 1992 | https://conductscience.org/library/papers/1380099 | PubMed |
| 14 | 1381201 | Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis. | AIDS Res Hum Retroviruses | 1992 | https://conductscience.org/library/papers/1381201 | PubMed |
| 15 | 1381908 | Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1. | Arch Virol | 1992 | https://conductscience.org/library/papers/1381908 | PubMed |
| 16 | 1388899 | Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals. | AIDS | 1992 | https://conductscience.org/library/papers/1388899 | PubMed |
| 17 | 7677959 | Complement activation by human monoclonal antibodies to human immunodeficiency virus. | J Virol | 1993 | https://conductscience.org/library/papers/7677959 | PubMed |
| 18 | 8417177 | Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. | J Acquir Immune Defic Syndr (1988) | 1993 | https://conductscience.org/library/papers/8417177 | PubMed |
| 19 | 7678308 | Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. | J Virol | 1993 | https://conductscience.org/library/papers/7678308 | PubMed |
| 20 | 7685405 | Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. | J Virol | 1993 | https://conductscience.org/library/papers/7685405 | PubMed |
Cited by648
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 991 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42774884 | Direct detection and quantification of HIV particles and their envelope trimers bound by combinations of broadly neutralizing antibodies. | iScience | 2026 | https://conductscience.org/library/papers/42774884 | PubMed |
| 42322610 | Comprehensive mapping of the virus and host factors that guide the paths of HIV-1 escape from a therapeutic. | Cell Rep | 2026 | https://conductscience.org/library/papers/42322610 | PubMed |
| 42207948 | Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection. | J Virol | 2026 | https://conductscience.org/library/papers/42207948 | PubMed |
| 42051541 | Comparing CD8+ T cell ENV epitopes of two HLA class I alleles associated with different outcomes of HIV-1 infection with broadly neutralizing antibodies epitope targets discovered to date. | Front Immunol | 2026 | https://conductscience.org/library/papers/42051541 | PubMed |
| 42019079 | Structural Insights Into Man9 Recognition by the HIV Antibody 2G12 Revealed by Paramagnetic NMR. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42019079 | PubMed |
| 41939861 | Immunomodulation by glycosylation: bridging glycobiology to adaptive immunity and therapeutic innovation. | Front Immunol | 2026 | https://conductscience.org/library/papers/41939861 | PubMed |
| 41917410 | The Biological Role of Enveloped Virus Glycosylation and Its Interactions with Antiviral Lectins. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41917410 | PubMed |
| 41789059 | Framework-mediated binding of foreign and self-glycans by IGHV4-34 antibodies. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789059 | PubMed |
| 41648506 | Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648506 | PubMed |
| 41497656 | Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic. | bioRxiv | 2025 | https://conductscience.org/library/papers/41497656 | PubMed |
| 40726783 | In Vitro Selection of Cyclized, Glycosylated Peptide Antigens That Tightly Bind HIV High Mannose Patch Antibodies. | ACS Cent Sci | 2025 | https://conductscience.org/library/papers/40726783 | PubMed |
| 40511646 | Germline-Targeting Strategies to Induce bNAbs against HIV-1. | Curr HIV Res | 2026 | https://conductscience.org/library/papers/40511646 | PubMed |
| 39988778 | The Germline Targeting Vaccine Concept: Overview and Updates from HIV Pre-Clinical and Clinical Trials. | Curr HIV Res | 2026 | https://conductscience.org/library/papers/39988778 | PubMed |
| 39932316 | Activation of CXCR3+ Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development. | J Virol | 2025 | https://conductscience.org/library/papers/39932316 | PubMed |
| 39836706 | Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/39836706 | PubMed |
| 39495223 | Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth. | Elife | 2024 | https://conductscience.org/library/papers/39495223 | PubMed |
| 39163866 | An explainable language model for antibody specificity prediction using curated influenza hemagglutinin antibodies. | Immunity | 2024 | https://conductscience.org/library/papers/39163866 | PubMed |
| 39122901 | Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing. | Commun Biol | 2024 | https://conductscience.org/library/papers/39122901 | PubMed |
| 38979012 | Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs. | iScience | 2024 | https://conductscience.org/library/papers/38979012 | PubMed |
| 38675791 | Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38675791 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8551569
GET https://conductscience.org/api/papers/v1/8551569/references?page=2